Yu ML - Search Results

1

Body weight increase and metabolic derangements after tenofovir disoproxil fumarate switch to tenofovir alafenamide in patients with chronic hepatitis B.

Cheng PN, Feng IC, Chen JJ, Kuo HT, Lee PL, Yu ML, Chiu YC, Chiu HC, Chien SC, Chen PJ, Liu CJ. Cheng PN, et al. Among authors: yu ml. Aliment Pharmacol Ther. 2024 Jan;59(2):230-238. doi: 10.1111/apt.17765. Epub 2023 Oct 16. Aliment Pharmacol Ther. 2024. PMID: 37845815

2

Genetic predisposition of responsiveness to therapy for chronic hepatitis C.

Hwang Y, Chen EY, Gu ZJ, Chuang WL, Yu ML, Lai MY, Chao YC, Lee CM, Wang JH, Dai CY, Shian-Jy Bey M, Liao YT, Chen PJ, Chen DS. Hwang Y, et al. Among authors: yu ml. Pharmacogenomics. 2006 Jul;7(5):697-709. doi: 10.2217/14622416.7.5.697. Pharmacogenomics. 2006. PMID: 16886895

3

Different viral kinetics between hepatitis C virus genotype 1 and 2 as on-treatment predictors of response to a 24-week course of high-dose interferon-alpha plus ribavirin combination therapy.

Yu ML, Chuang WL, Dai CY, Lee LP, Hsieh MY, Lin ZY, Chen SC, Hsieh MY, Wang LY, Chang WY, Tsai SL, Kuo HT. Yu ML, et al. Transl Res. 2006 Sep;148(3):120-7. doi: 10.1016/j.trsl.2006.04.006. Transl Res. 2006. PMID: 16938649

4

Peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses.

Liu CJ, Chuang WL, Lee CM, Yu ML, Lu SN, Wu SS, Liao LY, Chen CL, Kuo HT, Chao YC, Tung SY, Yang SS, Kao JH, Liu CH, Su WW, Lin CL, Jeng YM, Chen PJ, Chen DS. Liu CJ, et al. Among authors: yu ml. Gastroenterology. 2009 Feb;136(2):496-504.e3. doi: 10.1053/j.gastro.2008.10.049. Epub 2008 Oct 29. Gastroenterology. 2009. PMID: 19084016 Clinical Trial.

5

HBsAg profiles in patients receiving peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses.

Yu ML, Lee CM, Chuang WL, Lu SN, Dai CY, Huang JF, Lin ZY, Hu TH, Chen CH, Hung CH, Wang JH, Chen CL, Kao JH, Lai MY, Liu CH, Su TH, Wu SS, Liao LY, Kuo HT, Chao YC, Tung SY, Yang SS, Chen PJ, Liu CJ, Chen DS. Yu ML, et al. J Infect Dis. 2010 Jul 1;202(1):86-92. doi: 10.1086/653209. J Infect Dis. 2010. PMID: 20482252

6

Long-term effect of interferon plus ribavirin on hepatitis B surface antigen seroclearance in patients dually infected with hepatitis B and C viruses.

Yeh ML, Hung CH, Huang JF, Liu CJ, Lee CM, Dai CY, Wang JH, Lin ZY, Lu SN, Hu TH, Yu ML, Kao JH, Chuang WL, Chen PJ, Chen DS. Yeh ML, et al. Among authors: yu ml. PLoS One. 2011;6(6):e20752. doi: 10.1371/journal.pone.0020752. Epub 2011 Jun 13. PLoS One. 2011. PMID: 21695152 Free PMC article. Clinical Trial.

7

Interleukin-28B genetic variants in identification of hepatitis C virus genotype 1 patients responding to 24 weeks peginterferon/ribavirin.

Huang CF, Huang JF, Yang JF, Hsieh MY, Lin ZY, Chen SC, Wang LY, Juo SH, Chen KC, Chuang WL, Kuo HT, Dai CY, Yu ML. Huang CF, et al. Among authors: yu ml. J Hepatol. 2012 Jan;56(1):34-40. doi: 10.1016/j.jhep.2011.03.029. Epub 2011 May 19. J Hepatol. 2012. PMID: 21703176

8

Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving pegylated interferon-α-2a therapy.

Tseng TC, Yu ML, Liu CJ, Lin CL, Huang YW, Hsu CS, Liu CH, Kuo SF, Pan CJ, Yang SS, Su CW, Chen PJ, Chen DS, Kao JH. Tseng TC, et al. Among authors: yu ml. Antivir Ther. 2011;16(5):629-37. doi: 10.3851/IMP1841. Antivir Ther. 2011. PMID: 21817184

9

Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced hepatitis B e antigen seroconversion.

Yang HC, Chen CL, Shen YC, Peng CY, Liu CJ, Tseng TC, Su TH, Chuang WL, Yu ML, Dai CY, Liu CH, Chen PJ, Chen DS, Kao JH. Yang HC, et al. Among authors: yu ml. Hepatology. 2013 Mar;57(3):934-43. doi: 10.1002/hep.26121. Epub 2013 Feb 7. Hepatology. 2013. PMID: 23112104 Clinical Trial.

10

Sustained hepatitis C virus clearance and increased hepatitis B surface antigen seroclearance in patients with dual chronic hepatitis C and B during posttreatment follow-up.

Yu ML, Lee CM, Chen CL, Chuang WL, Lu SN, Liu CH, Wu SS, Liao LY, Kuo HT, Chao YC, Tung SY, Yang SS, Kao JH, Su WW, Lin CL, Yang HC, Chen PJ, Chen DS, Liu CJ; Taiwan Liver-Net Consortium. Yu ML, et al. Hepatology. 2013 Jun;57(6):2135-42. doi: 10.1002/hep.26266. Epub 2013 Apr 26. Hepatology. 2013. PMID: 23322699

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

760 results

Search Page